Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming ability

Molecular Cancer Research

Volumn 7, Issue 9, 2009, Pages 1477-1486

  Pattabiraman, Diwakar R ^a   Sun, Jane ^a   Dowhan, Dennis H ^a   Ishii, Shunsuke ^b   Gonda, Thomas J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b RIKEN TSUKUBA INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE PCAF; MUTANT PROTEIN; PROTEIN C MYB;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYO; GENE INTERACTION; GENE MUTATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; ONCOGENE C MYB; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTO ONCOGENE; TRANSACTIVATION;

ANIMALS; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID; MICE; MICE, INBRED CBA; MUTAGENESIS; MUTATION; P300-CBP TRANSCRIPTION FACTORS; POLYMERASE CHAIN REACTION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-MYB; TRANSCRIPTIONAL ACTIVATION;

MURINAE;

EID: 70349482360     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-09-0070     Document Type: Article

References (62)

1. Klempnauer KH, Gonda TJ, Bishop JM. Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene. Cell 1982;31:453-463
2. Leprince D, Gegonne A, Coll J, et al. A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature 1983;306:395-397 (Pubitemid 14242756)
3. Mucenski ML, McLain K, Kier AB, et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 1991;65:677-689
4. -/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling. Proc Natl Acad Sci U S A 2004;101:6553-6558
5. Sandberg ML, Sutton SE, Pletcher MT, et al. c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation. Dev Cell 2005;8:153-166 (Pubitemid 40197733)
6. Dudek H, Reddy EP. Murine myeloid leukemias with aberrant myb loci show heterogeneous expression of novel myb proteins. Oncogene 1989;4:1489-1495 (Pubitemid 20008929)
7. Mushinski JF, Potter M, Bauer SR, Reddy EP. DNA rearrangement and altered RNA expression of the c-myb oncogene in mouse plasmacytoid lymphosarcomas. Science 1983;220:795-798
8. Pelicci PG, Lanfrancone L, Brathwaite MD, Wolman SR, Dalla-Favera R. Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia. Science 1984;224:1117-1121 (Pubitemid 14106391)
9. Tomita A, Watanabe T, Kosugi H, et al. Truncated c-Myb expression in the human leukemia cell line TK-6. Leukemia 1998;12:1422-1429 (Pubitemid 28442390)
10. Clappier E, Cuccuini W, Kalota A, et al. The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. Blood 2007;110:1251-1261 (Pubitemid 47281423)
11. Lahortiga I, De Keersmaecker K, Van Vlierberghe P, et al. Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia. Nat Genet 2007;39:593-595 (Pubitemid 46676109)
12. Murati A, Gervais C, Carbuccia N, et al. Genome profiling of acute myelomonocytic leukemia: alteration of the MYB locus in MYST3-linked cases. Leukemia 2009;23:85-94.
13. Westin EH, Gallo RC, Arya SK, et al. Differential expression of the amv gene in human hematopoietic cells. Proc Natl Acad Sci U S A 1982;79:2194-2198 (Pubitemid 12093236)
14. Anfossi G, Gewirtz AM, Calabretta B. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. Proc Natl Acad Sci U S A 1989;86:3379-3383 (Pubitemid 19129615)
15. Calabretta B, Sims RB, Valtieri M, et al. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging. Proc Natl Acad Sci U S A 1991;88:2351-2355 (Pubitemid 21916414)
16. Biedenkapp H, Borgmeyer U, Sippel AE, Klempnauer KH. Viral myb oncogene encodes a sequence-specific DNA-binding activity. Nature 1988;335:835-837 (Pubitemid 18253411)
17. Ness SA, Marknell A, Graf T. The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene. Cell 1989;59:1115-1125 (Pubitemid 20024622)
18. Sakura H, Kanei-Ishii C, Nagase T, Nakagoshi H, Gonda TJ, Ishii S. Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. Proc Natl Acad Sci U S A 1989;86:5758-5762 (Pubitemid 19217533)
19. Dai P, Akimaru H, Tanaka Y, et al. CBP as a transcriptional coactivator of c-Myb. Genes Dev 1996;10:528-540
20. Gonda TJ. Molecular and cellular activities of Myb: regulation in normal hemopoiesis and transformation. Semin Virol 1991;2:351-361
21. Landschulz WH, Johnson PF, McKnight SL. The leucine zipper: a hypothetical structure common to a newclass of DNA binding proteins. Science 1988;240:1759-1764
22. Favier D, Gonda TJ. Detection of proteins that bind to the leucine zipper motif of c-Myb. Oncogene 1994;9:305-311 (Pubitemid 24020963)
23. Nomura T, Tanikawa J, Akimaru H, et al. Oncogenic activation of c-Myb correlates with a loss of negative regulation by TIF1β and Ski. J Biol Chem 2004;279:16715-16726 (Pubitemid 38509374)
24. Tavner FJ, Simpson R, Tashiro S, et al. Molecular cloning reveals that the p160 Myb-binding protein is a novel, predominantly nucleolar protein which may play a role in transactivation by Myb. Mol Cell Biol 1998;18:989-1002. (Pubitemid 28063433)
25. Dash AB, Orrico FC, Ness SA. The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb. Genes Dev 1996;10:1858-1869
26. Bies J, Wolff L. Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway. Oncogene 1997;14:203-212 (Pubitemid 27068306)
27. Lipsick JS, Wang DM. Transformation by v-Myb. Oncogene 1999;18:3047-3055
28. Stober-Grasser U, Lipsick JS. Specific amino acid substitutions are not required for transformation by v-myb of avian myeloblastosis virus. J Virol 1988;62:1093-1096 (Pubitemid 18068672)
29. Dini PW, Eltman JT, Lipsick JS. Mutations in the DNA-binding and transcriptional activation domains of v-Myb cooperate in transformation. J Virol 1995;69:2515-2524
30. Introna M, Golay J, Frampton J, Nakano T, Ness SA, Graf T. Mutations in v-myb alter the differentiation of myelomonocytic cells transformed by the oncogene. Cell 1990;63:1289-1297 (Pubitemid 120035077)
31. Ferrao P, Macmillan EM, Ashman LK, Gonda TJ. Enforced expression of full length c-Myb leads to density-dependent transformation of murine haemopoietic cells. Oncogene 1995;11:1631-1638
32. Fu SL, Lipsick JS. Constitutive expression of full-length c-Myb transforms avian cells characteristic of both the monocytic and granulocytic lineages. Cell Growth Differ 1997;8:35-45.
33. Gonda TJ, Buckmaster C, Ramsay RG. Activation of c-myb by carboxyterminal truncation: relationship to transformation of murine haemopoietic cells in vitro. EMBO J 1989;8:1777-1783 (Pubitemid 19273994)
34. Grasser FA, Graf T, Lipsick JS. Protein truncation is required for the activation of the c-myb proto-oncogene. Mol Cell Biol 1991;11:3987-3996 (Pubitemid 21895788)
35. Hu YL, Ramsay RG, Kanei-Ishii C, Ishii S, Gonda TJ. Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain. Oncogene 1991;6:1549-1553 (Pubitemid 21924256)
36. Kanei-Ishii C, MacMillan EM, Nomura T, et al. Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure. Proc Natl Acad Sci U S A 1992;89:3088-3092
37. Fu SL, Lipsick JS. FAETL motif required for leukemic transformation by v-Myb. J Virol 1996;70:5600-5610
38. Parker D, Rivera M, Zor T, et al. Role of secondary structure in discrimination between constitutive and inducible activators. Mol Cell Biol 1999;19:5601-5607 (Pubitemid 29339917)
39. Zor T, De Guzman RN, Dyson HJ, Wright PE. Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb. J Mol Biol 2004;337:521-534 (Pubitemid 38326874)
40. Alm-Kristiansen AH, Saether T, Matre V, Gilfillan S, Dahle O, Gabrielsen OS. FLASH acts as a co-activator of the transcription factor c-Myb and localizes to active RNA polymerase II foci. Oncogene 2008;27:4644-4656
41. Saether T, Berge T, Ledsaak M, et al. The chromatin remodeling factor Mi-2α acts as a novel co-activator for human c-Myb. J Biol Chem 2007;282:13994-14005 (Pubitemid 47100410)
42. Fan M, Rhee J, St-Pierre J, et al. Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1α: modulation by p38 MAPK. Genes Dev 2004;18:278-289 (Pubitemid 38199253)
43. Diaz VM, Mori S, Longobardi E, et al. p160 Myb-binding protein interacts with Prep1 and inhibits its transcriptional activity. Mol Cell Biol 2007;27:7981-7990 (Pubitemid 350086430)
44. Jones LC, Okino ST, Gonda TJ, Whitlock JP, Jr. Myb-binding protein 1a augments AhR-dependent gene expression. J Biol Chem 2002;277:22515-22519 (Pubitemid 34967225)
45. McCormack MP, Gonda TJ. Novel murine myeloid cell lines that exhibit a differentiation switch in response to IL-3 or GM-CSF, or to different constitutively active mutants of the GM-CSF receptor β subunit. Blood 2000;95:120-127
46. Brown AL, Wilkinson CR, Waterman SR, et al. Genetic regulators of myelopoiesis and leukemic signaling identified by gene profiling and linear modeling. J Leukoc Biol 2006;80:433-447
47. Britos-Bray M, Friedman AD. Core binding factor cannot synergistically activate the myeloperoxidase proximal enhancer in immature myeloid cells without c-Myb. Mol Cell Biol 1997;17:5127-5135 (Pubitemid 27357611)
48. Sano Y, Ishii S. Increased affinity of c-Myb for CREB-binding protein (CBP) after CBP-induced acetylation. J Biol Chem 2001;276:3674-3682 (Pubitemid 37411672)
49. Metcalf D. Hemopoietic regulators and leukemia development: a personal retrospective. Adv Cancer Res 1994;63:41-91. (Pubitemid 124006741)
50. Burk O, Mink S, Ringwald M, Klempnauer KH. Synergistic activation of the chicken mim-1 gene by v-myb and C/EBP transcription factors. EMBO J 1993;12:2027-2038 (Pubitemid 23157719)
51. Ness SA, Kowenz-Leutz E, Casini T, Graf T, Leutz A. Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types. Genes Dev 1993;7:749-759 (Pubitemid 23163580)
52. Mo X, Kowenz-Leutz E, Laumonnier Y, Xu H, Leutz A. Histone H3 tail positioning and acetylation by the c-Myb but not the v-Myb DNA-binding SANT domain. Genes Dev 2005;19:2447-2457 (Pubitemid 41483692)
53. -/- mice. Blood 2008;112:3148-3153
54. Leverson JD, Ness SA. Point mutations in v-Myb disrupt a cyclophilin-catalyzed negative regulatory mechanism. Mol Cell 1998;1:203-211
55. Pani E, Menigatti M, Schubert S, et al. Pin1 interacts with c-Myb in a phosphorylation-dependent manner and regulates its transactivation activity. Biochim Biophys Acta 2008;1783:1121-1128
56. Ramsay RG, Gonda TJ. MYB function in normal and cancer cells. Nat Rev Cancer 2008;8:523-534 (Pubitemid 351881853)
57. Boger DL, Desharnais J, Capps K. Solution-phase combinatorial libraries: modulating cellular signaling by targeting protein-protein or protein-DNA interactions. Angew Chem Int Ed Engl 2003;42:4138-4176 (Pubitemid 37168929)
58. Polo JM, Dell'Oso T, Ranuncolo SM, et al. Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells. Nat Med 2004;10:1329-1335 (Pubitemid 40022714)
59. Tanikawa J, Nomura T, Macmillan EM, et al. p53 suppresses c-Myb-induced trans-activation and transformation by recruiting the corepressor mSin3A. J Biol Chem 2004;279:55393-55400 (Pubitemid 40066539)
60. Kitamura T, Koshino Y, Shibata F, et al. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol 2003;31:1007-1014 (Pubitemid 37329742)
61. Persons DA, Mehaffey MG, Kaleko M, Nienhuis AW, Vanin EF. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene. Blood Cells Mol Dis 1998;24:167-182 (Pubitemid 28365736)
62. Nomura T, Sakai N, Sarai A, et al. Negative autoregulation of c-Myb activity by homodimer formation through the leucine zipper. J Biol Chem 1993;268:21914-21923 (Pubitemid 23320696)